Euroespes SA
MAD:EEP
Euroespes SA
MAD:EEP
Price:
0.34
EUR
Market Closed
Market Cap:
€4m
Relative Value
There is not enough data to reliably calculate the relative value of EEP.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EEP
Relative Value
Base Case
Not Available
Multiples Across Competitors
EEP Competitors Multiples
Euroespes SA Competitors
Euroespes SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ES |
|
Euroespes SA
MAD:EEP
|
3.9m EUR | 1.2 | -3.4 | -18.5 | -4.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 393.6 | 4 660.8 | 1 477.6 | 3 157 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
202.9B USD | 4.6 | 30.3 | 21 | 28.2 | |
| US |
|
Danaher Corp
NYSE:DHR
|
155B USD | 6.3 | 42.9 | 23.7 | 36 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
46.3T KRW | 14.5 | 50 | 29.3 | 39.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.5B CHF | 5.5 | 37.9 | 27.8 | 27.8 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
289.2B CNY | 6.6 | 19.4 | 19.6 | 19.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
36.4B USD | 5.2 | 27.9 | 20.4 | 24.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
31B USD | 1.9 | 22.7 | 12.4 | 18.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.6B USD | 7.1 | 32.9 | 24.3 | 27 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
162.8B HKD | 7.2 | 34.3 | 24.1 | 24.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
